Self-reported suboptimal sleep and receipt of sleep assessment and treatment among persons with and without a mental health condition in Australia: a cross sectional study.

Assessment Care provision Health risk behaviour Mental health conditions Sleep Treatment

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
06 03 2021
Historique:
received: 05 05 2020
accepted: 25 02 2021
entrez: 7 3 2021
pubmed: 8 3 2021
medline: 22 5 2021
Statut: epublish

Résumé

Poor sleep and poor mental health go hand in hand and, together, can have an adverse impact on physical health. Given the already disproportionate physical health inequities experienced by people with a mental health condition worldwide, the need to consider and optimise sleep has been highlighted as a means of improving both physical and mental health status. Sleep recommendations recently developed by the United States' National Sleep Foundation incorporate a range of sleep parameters and enable the identification of 'suboptimal' sleep. Among community-dwelling persons with and without a 12-month mental health condition in Australia, this study reports: [1] the prevalence of 'suboptimal' sleep and [2] rates of sleep assessment by a health care clinician/service and receipt of and desire for sleep treatment. A descriptive study (N = 1265) was undertaken using self-report data derived from a cross-sectional telephone survey of Australian adults, undertaken in 2017. Fifteen per cent (n = 184) of participants identified as having a mental health condition in the past 12 months. Across most (7 of 8) sleep parameters, the prevalence of suboptimal sleep was higher among people with a mental health condition, compared to those without (all p < 0.05). The highest prevalence of suboptimal sleep for both groups was seen on measures of sleep duration (36-39% and 17-20% for people with and without a mental health condition, respectively). In terms of sleep assessment and treatment, people with a mental health condition were significantly more likely to: desire treatment (37% versus 16%), have been assessed (38% versus 12%) and have received treatment (30% versus 7%). The prevalence of suboptimal sleep among persons with a mental health condition in Australia is significantly higher than those without such a condition, and rates of assessment and treatment are low for both groups, but higher for people with a mental health condition. Population health interventions, including those delivered as part of routine health care, addressing suboptimal sleep are needed.

Sections du résumé

BACKGROUND
Poor sleep and poor mental health go hand in hand and, together, can have an adverse impact on physical health. Given the already disproportionate physical health inequities experienced by people with a mental health condition worldwide, the need to consider and optimise sleep has been highlighted as a means of improving both physical and mental health status. Sleep recommendations recently developed by the United States' National Sleep Foundation incorporate a range of sleep parameters and enable the identification of 'suboptimal' sleep. Among community-dwelling persons with and without a 12-month mental health condition in Australia, this study reports: [1] the prevalence of 'suboptimal' sleep and [2] rates of sleep assessment by a health care clinician/service and receipt of and desire for sleep treatment.
METHODS
A descriptive study (N = 1265) was undertaken using self-report data derived from a cross-sectional telephone survey of Australian adults, undertaken in 2017.
RESULTS
Fifteen per cent (n = 184) of participants identified as having a mental health condition in the past 12 months. Across most (7 of 8) sleep parameters, the prevalence of suboptimal sleep was higher among people with a mental health condition, compared to those without (all p < 0.05). The highest prevalence of suboptimal sleep for both groups was seen on measures of sleep duration (36-39% and 17-20% for people with and without a mental health condition, respectively). In terms of sleep assessment and treatment, people with a mental health condition were significantly more likely to: desire treatment (37% versus 16%), have been assessed (38% versus 12%) and have received treatment (30% versus 7%).
CONCLUSIONS
The prevalence of suboptimal sleep among persons with a mental health condition in Australia is significantly higher than those without such a condition, and rates of assessment and treatment are low for both groups, but higher for people with a mental health condition. Population health interventions, including those delivered as part of routine health care, addressing suboptimal sleep are needed.

Identifiants

pubmed: 33676472
doi: 10.1186/s12889-021-10504-6
pii: 10.1186/s12889-021-10504-6
pmc: PMC7937198
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

463

Subventions

Organisme : University of Newcastle's Priority Research Centre for Health Behaviour
ID : N/A

Commentaires et corrections

Type : ErratumIn

Références

Acta Neuropsychiatr. 2011 Oct;23(5):201-209
pubmed: 28183388
Lancet Psychiatry. 2019 Aug;6(8):675-712
pubmed: 31324560
Sleep Health. 2018 Feb;4(1):13-19
pubmed: 29332673
Psychol Psychother. 2016 Jun;89(2):181-93
pubmed: 26285922
Prev Chronic Dis. 2013 Aug 08;10:E133
pubmed: 23928458
Sleep Health. 2015 Dec;1(4):233-243
pubmed: 29073398
Sleep Med Rev. 2010 Jun;14(3):191-203
pubmed: 19932976
Sleep Health. 2017 Feb;3(1):35-42
pubmed: 28346149
Prev Med. 2014 Mar;60:102-6
pubmed: 24380793
Am Fam Physician. 2007 Aug 15;76(4):517-26
pubmed: 17853625
Sleep. 2016 Apr 01;39(4):833-46
pubmed: 26446114
Chronobiol Int. 2006;23(1-2):497-509
pubmed: 16687322
J Int Neuropsychol Soc. 2011 Jul;17(4):571-86
pubmed: 21554786
Lancet Psychiatry. 2020 Jan;7(1):52-63
pubmed: 31787585
BMJ. 2013 May 21;346:f2539
pubmed: 23694688
J Psychopharmacol. 2010 Nov;24(4 Suppl):61-8
pubmed: 20923921
Sleep Health. 2019 Feb;5(1):12-17
pubmed: 30670159
Psychol Med. 2018 Jul;48(10):1694-1704
pubmed: 29108526
Psychiatry Res. 2019 Sep;279:116-122
pubmed: 30072039
Ann Epidemiol. 2013 Jun;23(6):361-70
pubmed: 23622956
Circulation. 2016 Nov 1;134(18):e367-e386
pubmed: 27647451
Sleep Health. 2018 Apr;4(2):182-187
pubmed: 29555132
Nat Hum Behav. 2020 Jan;4(1):100-110
pubmed: 31685950
Front Psychol. 2015 Jul 14;6:990
pubmed: 26236265
BMC Psychiatry. 2014 Feb 08;14:33
pubmed: 24506941
Curr Epidemiol Rep. 2018 Jun;5(2):61-69
pubmed: 29984131
Sleep Med. 2011 Mar;12(3):215-21
pubmed: 21317033
Fam Pract. 2018 Jul 23;35(4):365-375
pubmed: 29194467
Lancet Psychiatry. 2017 Oct;4(10):749-758
pubmed: 28888927
Sleep Health. 2017 Feb;3(1):6-19
pubmed: 28346153
Health Rep. 2017 Sep 20;28(9):28-33
pubmed: 28930365
Gen Hosp Psychiatry. 2015 Nov-Dec;37(6):501-6
pubmed: 26160056
Schizophr Bull. 2019 Mar 7;45(2):287-295
pubmed: 30202909
Sleep. 2010 Apr;33(4):531-8
pubmed: 20394323
Psychol Bull. 2012 Jan;138(1):77-101
pubmed: 21967449
BMC Psychiatry. 2012 Oct 29;12:179
pubmed: 23107000
J Clin Sleep Med. 2015 Jan 15;11(2):111-6
pubmed: 25348241
NIH Consens State Sci Statements. 2005 Jun 13-15;22(2):1-30
pubmed: 17308547
BMC Psychiatry. 2017 May 2;17(1):158
pubmed: 28464848
J Sleep Res. 2009 Jun;18(2):148-58
pubmed: 19645960
J Abnorm Psychol. 2009 Aug;118(3):448-58
pubmed: 19685943
Soc Sci Med. 2010 Sep;71(5):1027-36
pubmed: 20621406
J Clin Sleep Med. 2011 Feb 15;7(1):41-8
pubmed: 21344054
Health Qual Life Outcomes. 2003 Sep 02;1:37
pubmed: 14498988
Dialogues Clin Neurosci. 2008;10(4):473-81
pubmed: 19170404
Sleep Sci. 2016 Jul-Sep;9(3):202-206
pubmed: 28123661
BMC Public Health. 2016 Oct 31;16(Suppl 3):1029
pubmed: 28185594
Sleep Med Rev. 2019 Feb;43:96-105
pubmed: 30537570
Sci Rep. 2019 Aug 19;9(1):12011
pubmed: 31427590
Sleep Health. 2020 Feb;6(1):100-109
pubmed: 31718947
Clin Ther. 2005 Dec;27(12):1970-9
pubmed: 16507384

Auteurs

Alexandra P Metse (AP)

University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia. alexandra.metse@uon.edu.au.
University of the Sunshine Coast, 90 Sippy Downs Drive, Sippy Downs, QLD, 4556, Australia. alexandra.metse@uon.edu.au.
Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia. alexandra.metse@uon.edu.au.
Murdoch University, 90 South Street, Murdoch, WA, 6150, Australia. alexandra.metse@uon.edu.au.

Caitlin Fehily (C)

University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.

Tara Clinton-McHarg (T)

University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.

Olivia Wynne (O)

University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.

Sharon Lawn (S)

Flinders University, Sturt Rd, Bedford Park, SA, 5042, Australia.

John Wiggers (J)

University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.
Hunter New England Population Health, Longworth Avenue, Wallsend, NSW, 2287, Australia.

Jenny A Bowman (JA)

University of Newcastle, University Drive, Callaghan, NSW, 2308, Australia.
Hunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH